DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX (Q2019366)

From EU Knowledge Graph
Revision as of 22:11, 12 February 2022 by DG Regio (talk | contribs) (‎Changed an Item: Edited by the materialized bot - inferring region from the coordinates)
Jump to navigation Jump to search
Project Q2019366 in Italy
Language Label Description Also known as
English
DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX
Project Q2019366 in Italy

    Statements

    country
    Italy
    0 references
    EU contribution
    964,438.71 Euro
    0 references
    budget
    1,329,656.71 Euro
    0 references
    co-financing rate
    72.53 percent
    0 references
    start time
    1 November 2016
    0 references
    expected end time
    31 December 2018
    0 references
    beneficiary name (string)
    NOUSCOM SOCIETA' A RESPONSABILITA' LIMITATA
    0 references
    beneficiary
    Q277382
    0 references
    coordinate location

    40°50'9.17"N, 14°14'55.57"E
    0 references

    41°53'35.95"N, 12°28'58.55"E
    0 references
    summary
    BIOTECNOLOGIE (Italian)
    0 references
    BIOTECHNOLOGY (English)
    0 references
    BIOTECHNOLOGIE (French)
    point in time
    14 December 2021
    0 references
    BIOTECHNOLOGIE (Dutch)
    point in time
    22 December 2021
    0 references
    BIOTECHNOLOGIE (German)
    point in time
    24 December 2021
    0 references
    BIOTECNOLOGÍA (Spanish)
    point in time
    24 January 2022
    0 references
    location (string)
    ROMA
    0 references
    NAPOLI
    0 references

    Identifiers

    Italian Unique Project Code
    B88I17000390008
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q2019366&oldid=27948931"